Search

everythinglearnresearchcommunity

for

Search:↓

ZPK helps skin cells mature and may affect skin health.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Probiotics with Lactobacillus reuteri improve IBS symptoms in children.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

A woman with severe angioedema improved significantly after treatment with rituximab.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Henna ointment may help reduce itching and improve wound healing in patients with epidermolysis bullosa.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

QLT0267 stops hair follicle cell growth and movement.

A woman with lupus also developed a severe skin condition linked to a genetic factor.

Dupilumab can cause rare side effects like a rash on the face and neck.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.